Grant, Rebecca and Niebel, Dennis and Hunt, William and Tso, Simon (2025) Variability in triple bottom line commitments of multinational pharmaceutical and cosmeceutical companies: insights from 2023 corporate and environmental, social and governance reports. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 50 (8). pp. 1578-1582. ISSN 0307-6938, 1365-2230
Full text not available from this repository. (Request a copy)Abstract
Background The triple bottom line is a framework for evaluating organizational performance incorporating environmental, social and economic impacts.Objectives To examine the triple bottom line commitments of multinational corporates operating in the dermatology field with a specific focus on environmental goals.Methods A convenience sample of 10 pharmaceutical and 6 cosmeceutical corporates were included in this study. We performed a retrospective secondary data analysis of their published 2023 corporate annual reports and environmental, social and governance (ESG) reports, and reviewed their commitments.Results All corporates except three pharmaceuticals (81%, 13/16) published a target year to reach carbon net zero or neutrality for greenhouse gas (GHG) protocol scopes 1 (direct emissions from performing its business activities) and 2 (indirect emissions from purchased energy) [median year 2040; range 2025-2050; 95% confidence interval (CI) 2035-2045]. All corporates except four pharmaceuticals (75%, 12/16) published a target year to reach carbon net zero or neutrality for GHG scope 3 (indirect emissions from the value chain; median year 2043; range 2026-2050; 95% CI 2038-2047).Conclusions All net zero or carbon neutrality plans identified have outlined the potential inclusion or actual utilization of carbon offsetting schemes or carbon removal schemes in achieving their goals. For cosmeceuticals, all but one corporate (83%, 5/6) participate in the EcoBeautyScore Association. This study highlighted variability in their ambitions in environmental goals. This study highlights variability in the triple bottom line commitments of multinational corporates, in particular, their ambitions about environmental goals.
| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Dermatologie und Venerologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 23 Sep 2026 07:51 |
| Last Modified: | 23 Sep 2026 07:51 |
| URI: | https://pred.uni-regensburg.de/id/eprint/67121 |
Actions (login required)
 |
View Item |
